Showing results (241-250 of 548) with videos related to
Sort By:
Pageof 55
American Journal of Hypertension|June 11, 2019
Blood Pressure, Chronic Kidney Disease Progression, and Kidney Allograft Failure in Kidney Transplant Recipients: A Secondary Analysis of the FAVORIT TrialRakesh Malhotra, Ronit Katz, Daniel E Weiner, et al.Journal of the American Society of Nephrology : JASN|November 30, 1999
Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study groupA S Levey, T Greene, G J Beck, et al.Journal of the American Society of Nephrology : JASN|February 16, 2007
Lowest systolic blood pressure is associated with stroke in stages 3 to 4 chronic kidney diseaseDaniel E Weiner, Hocine Tighiouart, Andrew S Levey, et al.Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|June 30, 2020
Nomenclature for Kidney Function and Disease: Executive Summary and Glossary From a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus ConferenceAndrew S Levey, Kai-Uwe Eckardt, Nijsje M Dorman, et al.The Journal of Clinical Investigation|June 1, 1975
Metabolism of bovine parathyroid hormone. Immunological and biological characteristics of fragments generated by liver perfusionJ M Canterbury, L A Bricker, G S Levey, et al.The American Journal of Medicine|May 26, 2007
Kidney disease, Framingham risk scores, and cardiac and mortality outcomesDaniel E Weiner, Hocine Tighiouart, John L Griffith, et al.Transplantation|September 23, 2025
Safety and Tolerability of Sotagliflozin Among Kidney Transplant RecipientsMartina M McGrath, Finnian R Mc Causland, Brian L Claggett, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 31, 2002
Homocysteine, cysteine, and B vitamins as predictors of kidney disease progressionMark J Sarnak, Shin-Ru Wang, Gerald J Beck, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 3, 2014
Utility and validity of estimated GFR-based surrogate time-to-event end points in CKD: a simulation studyTom Greene, Chia-Chen Teng, Lesley A Inker, et al.Controlled Clinical Trials|May 22, 2003
Constructing a database of individual clinical trials for longitudinal analysisChristopher H Schmid, Marcia Landa, Tazeen H Jafar, et al.Pageof 55